🇺🇸 FDA
Patent

US 10653789

Polymer-drug conjugates for combination anticancer therapy

granted A61KA61K31/4745A61K31/704

Quick answer

US patent 10653789 (Polymer-drug conjugates for combination anticancer therapy) held by The Regents of the University of California expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4745, A61K31/704, A61K31/7068, A61K47/61